The cholesterol drug Lipitor may be linked to an increased risk of type 2 diabetes in otherwise healthy and active users. As a result of Pfizer’s failure to adequately warn about this potential risk, former users may be entitled to financial compensation through a Lipitor diabetes lawsuit. LIPITOR DIABETES LAWSUIT STATUS: In January 2017, a federal judge granted summary judgment in favor of the defendants. However, some product liability lawsuits are still being reviewed by Lipitor lawyers for diabetes suffered by individuals throughout the United States.   >>SUBMIT INFORMATION ABOUT A LIPITOR LAWSUIT<< OVERVIEW: Lipitor (atorvastatin) is a statin-based cholesterol drug developed…